MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma.
Zhan Y, Guo J, Yang W, Goncalves C, Rzymski T, Dreas A, Żyłkiewicz E, Mikulski M, Brzózka K, Golas A, Kong Y, Ma M, Huang F, Huor B, Guo Q, da Silva SD, Torres J, Cai Y, Topisirovic I, Su J, Bijian K, Alaoui-Jamali MA, Huang S, Journe F, Ghanem GE, Miller WH Jr, Del Rincón SV.
Zhan Y, et al. Among authors: alaoui jamali ma.
J Clin Invest. 2024 Apr 15;134(8):e181338. doi: 10.1172/JCI181338.
J Clin Invest. 2024.
PMID: 38618965
Free PMC article.
No abstract available.